tiprankstipranks
Trending News
More News >
Ivy Cosmetics Corporation (JP:4918)
:4918
Japanese Market
Advertisement

Ivy Cosmetics Corporation (4918) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4918

Ivy Cosmetics Corporation

(4918)

Rating:68Neutral
Price Target:
¥335.00
▲(0.00% Upside)
Ivy Cosmetics Corporation's stock score is primarily driven by its strong financial performance and attractive valuation. The company shows a solid recovery trajectory with robust cash flow generation and a strong balance sheet. However, technical indicators suggest short-term bearish momentum, which slightly offsets the overall positive outlook.
Positive Factors
Revenue Growth
The company's ability to rebound with nearly 8% revenue growth indicates resilience and potential for sustained market expansion.
Balance Sheet Strength
A strong equity ratio suggests financial stability, providing a solid foundation for future growth and reducing financial risk.
Cash Generation
Strong cash generation enhances liquidity and supports operational needs, enabling reinvestment and strategic initiatives.
Negative Factors
Low Profitability
Low profitability may hinder reinvestment and growth, posing challenges in achieving long-term financial objectives.
Modest Return on Equity
A modest return on equity suggests inefficiencies in generating returns, potentially impacting investor confidence and capital attraction.
Declining EBITDA Margin
A declining EBITDA margin suggests rising costs outside core operations, which could pressure overall profitability and strategic flexibility.

Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)

Ivy Cosmetics Corporation Business Overview & Revenue Model

Company DescriptionIvy Cosmetics Corporation (4918) is a Japanese company that specializes in the development, manufacture, and distribution of cosmetic products. The company operates in the beauty and personal care industry, offering a wide range of skincare, makeup, and hair care products. Known for its commitment to quality and innovation, Ivy Cosmetics focuses on meeting diverse consumer needs through its extensive product lines.
How the Company Makes MoneyIvy Cosmetics Corporation generates revenue primarily through the sale of its cosmetic products, which include skincare, makeup, and hair care items. The company distributes its products through various channels, including retail stores, e-commerce platforms, and direct sales. By leveraging brand recognition and consumer loyalty, Ivy Cosmetics maintains a strong market presence. Additionally, the company may form strategic partnerships with retailers and distributors to expand its market reach and enhance its sales performance.

Ivy Cosmetics Corporation Financial Statement Overview

Summary
Ivy Cosmetics Corporation shows a solid recovery with improving revenue and operational metrics. The balance sheet is strong with low leverage, enhancing financial stability. Cash flow generation is robust, supporting liquidity and operational needs. However, challenges remain in consistently translating revenue growth into higher profitability.
Income Statement
65
Positive
Ivy Cosmetics Corporation has experienced a recent recovery in revenue growth, with a 7.95% increase from 2024 to 2025, following a decline in prior years. Gross profit margin remains strong at 70.5% in 2025, indicating efficient cost control. However, the net profit margin is low at 1.47%, reflecting challenges in converting revenue into profit. The EBIT margin improved significantly to 14.42% in 2025 from previous negative margins, showing operational improvements, though EBITDA margin has declined, indicating higher non-operational expenses.
Balance Sheet
72
Positive
The balance sheet shows a strong equity position with an equity ratio of 69.19% in 2025, indicating financial stability. The debt-to-equity ratio has improved to 0.14, suggesting effective debt management. Return on equity, however, is modest at 1.74%, indicating limited profitability relative to shareholder investments. The overall leverage is low, reducing financial risk.
Cash Flow
78
Positive
Cash flow analysis reveals robust free cash flow growth of 3.91% from 2024 to 2025, indicating strong cash generation capability. The operating cash flow to net income ratio is high at 10.37, reflecting efficient cash operations. The company's ability to convert net income into free cash flow is impressive, with a ratio of 9.87, highlighting effective capital expenditure management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.93B2.71B2.94B3.53B3.43B
Gross Profit2.07B1.91B2.11B2.42B2.14B
EBITDA20.62M242.60M-33.16M185.13M255.05M
Net Income43.01M160.31M-384.61M40.38M-23.23M
Balance Sheet
Total Assets3.57B3.57B3.85B4.35B4.72B
Cash, Cash Equivalents and Short-Term Investments577.94M208.73M247.67M129.38M113.43M
Total Debt339.85M451.69M1.05B1.18B1.79B
Total Liabilities1.10B1.33B1.87B2.09B3.20B
Stockholders Equity2.47B2.24B1.98B2.27B1.51B
Cash Flow
Free Cash Flow424.68M408.70M243.33M-160.58M374.53M
Operating Cash Flow445.94M453.06M278.59M-107.06M427.02M
Investing Cash Flow-18.43M7.30M-29.30M63.30M330.37M
Financing Cash Flow-58.27M-499.31M-131.00M59.71M-693.39M

Ivy Cosmetics Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price335.00
Price Trends
50DMA
320.10
Positive
100DMA
314.70
Positive
200DMA
279.72
Positive
Market Momentum
MACD
4.70
Negative
RSI
59.74
Neutral
STOCH
66.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Positive. The current price of 335 is above the 20-day moving average (MA) of 319.60, above the 50-day MA of 320.10, and above the 200-day MA of 279.72, indicating a bullish trend. The MACD of 4.70 indicates Negative momentum. The RSI at 59.74 is Neutral, neither overbought nor oversold. The STOCH value of 66.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4918.

Ivy Cosmetics Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
¥1.75B5.21
8.96%
62
Neutral
$20.56B14.66-3.18%3.15%1.93%-6.58%
$452.94M43.213.06%1.55%
73
Outperform
¥41.37B28.93
1.43%6.10%13.84%
63
Neutral
¥6.60B10.31
2.29%-3.27%
60
Neutral
¥6.16B159.76
1.56%-9.81%
45
Neutral
¥5.16B20.49
1.66%7.21%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4918
Ivy Cosmetics Corporation
335.00
40.00
13.56%
MDOMF
Mandom
12.71
4.38
52.58%
JP:4923
Cota Co., Ltd.
1,412.00
-194.22
-12.09%
JP:4925
HABA Laboratories, Inc.
1,746.00
-205.98
-10.55%
JP:4926
C'BON COSMETICS Co., Ltd.
1,207.00
-74.20
-5.79%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
766.00
-32.30
-4.05%

Ivy Cosmetics Corporation Corporate Events

Ivy Cosmetics Faces Financial Challenges in Q1 2025
Aug 6, 2025

Ivy Cosmetics Corporation reported a significant decline in its financial performance for the first quarter ending June 2025. The company experienced a 15.7% decrease in net sales compared to the previous year, alongside operating and ordinary losses. Despite these challenges, the capital adequacy ratio improved to 74.9%, indicating a strong equity position. The company did not declare any dividends for the quarter, reflecting its focus on stabilizing operations amidst financial setbacks.

Ivy Cosmetics Reports Strong Profit Growth Amidst Declining Net Profit
May 14, 2025

Ivy Cosmetics Corporation reported a significant increase in operating and ordinary profits for the fiscal year ending March 2025, with operating profit rising by 125.9% and ordinary profit by 124.2%. Despite a decline in net profit by 73.2%, the company improved its capital adequacy ratio to 69.2%, indicating a stronger financial position, which may positively impact its market standing and stakeholder confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 22, 2025